| |
| |
|
| Insider
Information: |
Muralidhar Bali |
| Relationship: |
Director |
| City: |
Skokie |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
12,315,601 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$7,688,916 |
|
|
| Total
Shares |
12,315,601 |
|
|
| Total
Value |
$7,688,916 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exicure Ord Shs |
XCUR |
Director |
|
0 |
2022-05-19 |
8,449,126 |
Premium* |
|
|
Spruce Biosciences, Inc. |
SPRB |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,792,518 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
Director |
2021-04-13 |
0 |
2021-07-14 |
2,073,957 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XCUR |
Exicure Ord Shs |
Director |
– • – |
2022-05-19 |
4 |
B |
$0.19 |
$285,151 |
I/I |
1,472,126 |
8,449,126 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-07-14 |
4 |
B |
$8.50 |
$949,756 |
I/I |
111,736 |
2,073,957 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-23 |
4 |
B |
$9.28 |
$192,245 |
I/I |
20,710 |
1,962,221 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-22 |
4 |
B |
$8.72 |
$127,487 |
I/I |
14,615 |
1,941,511 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-21 |
4 |
B |
$9.03 |
$294,927 |
I/I |
32,659 |
1,926,896 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-08 |
4 |
B |
$9.50 |
$157,709 |
I/I |
16,605 |
1,894,237 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-04 |
4 |
B |
$9.42 |
$2,422 |
I/I |
257 |
1,877,632 |
2.02 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-06-03 |
4 |
B |
$9.25 |
$111,943 |
I/I |
12,100 |
1,877,375 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-05-28 |
4 |
B |
$9.50 |
$133 |
I/I |
14 |
1,865,275 |
2.02 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-05-27 |
4 |
B |
$9.26 |
$10,369 |
I/I |
1,120 |
1,865,261 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-05-26 |
4 |
B |
$9.38 |
$55,495 |
I/I |
5,915 |
1,864,141 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-04-13 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
1,858,226 |
2.1 |
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
Director |
– • – |
2021-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,658,226 |
1,658,226 |
0 |
- |
|
| SPRB |
Spruce Biosciences, Inc. |
Director |
– • – |
2020-10-14 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
1,792,518 |
2.1 |
- |
|
| SPRB |
Spruce Biosciences, Inc. |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,592,518 |
1,592,518 |
0 |
- |
|
| XCUR |
Exicure Ord Shs |
Director |
– • – |
2019-12-19 |
4 |
B |
$2.75 |
$1,999,250 |
I/I |
727,000 |
6,977,000 |
2.1 |
- |
|
| XCUR |
Exicure Ord Shs |
Director |
– • – |
2019-08-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,250,000 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
